O_15: Identification of long-acting NRTI candidates through in silico modelling- Marco Siccardi, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Durability of first‐line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) - Ruth Goodall

International Workshop on HIV & Pediatrics 2015

Access to HIV, HBV, and HCV Antiviral Agents Globally- John Martin, PhD

HEP DART 2017

Resistance to integrase inhibitors- What clinicians need to know- Roger Paredes, MD, PhD

European HIV Clinical Forum 2018

Sofosbuvir and Ribavirin therapy for the Treatment of HIV/HCV co-infected patients with HCV GT1-4 Infection: The PHOTON-1 and -2 Trials|||| Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1 | Dr. J. Rockstroh

APACC 2016

Prospects for Gene Editing in CHB Cure Regimens_Fabien Zoulim.pdf

International Workshop on HBV Cure 2024

Vaccination for Mpox - What Do We Know? - Chloe Orkin, MBChB, FRCP, MD

Mpox Clinical Forum 2024

Program Book - International Workshop on HIV Pediatrics 2021

RIO HCF2024_Session 4_Pablo Tebas

Rio de Janeiro HIV Clinical Forum 2024

Liver Transplantation Egypt/SA Model - Cote d’Ivore - Elie Keli

Conference on Liver Disease in Africa (COLDA) 2022